IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vida Ventures Advisors, LLC

Q3 2024 Holdings

Filed 2024-10-08 | 6 holdings | $138.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Centessa Pharmaceuticals plc(CNTA)Ordinary Shares152309100$62.9M3,931,81845.4%
Tectonic Therapeutics, Inc.(TECX)Common Stock878972108$31.2M1,028,67422.5%
Kyverna Therapeutics, Inc.(KYTX)Common Stock501976104$22.1M4,523,92416.0%
Dyne Therapeutics, Inc.(DYN)Common Stock26818M108$14.6M407,49910.6%
Allogene Therapeutics, Inc.(ALLO)Common Stock019770106$5.0M1,798,1633.6%
Kronos Bio, Inc.(KRON1USD)Common Stock50107A104$2.8M2,765,3142.0%